Rathbones Group PLC - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 96 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
Rathbones Group PLC ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$395,000
+12.5%
40,784
-4.0%
0.00%0.0%
Q1 2021$351,000
+21.0%
42,4840.0%0.00%0.0%
Q4 2020$290,000
-38.8%
42,4840.0%0.00%
-50.0%
Q3 2020$474,000
+65.7%
42,484
-6.6%
0.01%
+33.3%
Q2 2020$286,000
+232.6%
45,484
-2.8%
0.01%
+100.0%
Q1 2020$86,000
-58.9%
46,784
-24.3%
0.00%
-50.0%
Q4 2019$209,000
+58.3%
61,7840.0%0.01%
+50.0%
Q3 2019$132,00061,7840.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 15,001$1,4100.00%
KLCM Advisors, Inc. 20,000$1,8800.00%
AlphaMark Advisors, LLC 3,135$00.00%
TRUST CO OF VERMONT 204$190.00%
SlateStone Wealth, LLC 30,866$30.00%
Coppell Advisory Solutions LLC 100$890.00%
Highlander Capital Management, LLC 1,200$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Russell Investments Group, Ltd. 266$250.00%
OGOREK ANTHONY JOSEPH /NY/ /ADV 3,600$00.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders